skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
ADE Regimen (Code C67207)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Concept Status: Retired Concept  (See:  ADE Regimen )

Preferred Name: ADE Regimen

Definition: A regimen consisting of cytarabine (Ara-C), daunorubicin and etoposide, that is used as an induction treatment for pediatric acute myeloid leukemia (AML).

Label: ADE Regimen

NCI Thesaurus Code: C67207 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL371491  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
ADE Regimen
AraC-Daunorubicin-Etoposide Regimen
Cytarabine-Daunorubicin-Etoposide Regimen
MRC AML10 Study-ADE Regimen

External Source Codes: 
PDQ Closed Trial Search ID 656988
PDQ Open Trial Search ID 656988 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C67207
Concept_Status Retired_Concept
deprecated true
DesignNote Fri Sep 24 12:54:54 EDT 2010 - See 'Cytarabine_Daunorubicin_Etoposide'
DesignNote Source: PDQ
Legacy_Concept_Name ADE_Regimen
OLD_PARENT Chemotherapy_Regimen_Used_to_Treat_Childhood_Acute_Myeloid_Leukemia
OLD_ROLE Chemotherapy_Regimen_Has_Component some Cytarabine
OLD_ROLE Chemotherapy_Regimen_Has_Component some Daunorubicin
OLD_ROLE Chemotherapy_Regimen_Has_Component some Etoposide
OLD_ROLE Regimen_Has_Accepted_Use_For_Disease some 'Childhood Acute Myeloid Leukemia'
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom